Corteva Inc's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), Corteva Inc reported revenue of $17.4B (+2.9% year on year) and net income of $1.1B (+20.2% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net Sales | $17.4B | $16.9B | $17.2B | $17.5B |
| Cost of Goods Sold | $9.2B | $9.5B | $9.9B | $10.4B |
| Research and Development Expense | $1.5B | $1.4B | $1.3B | $1.2B |
| Selling, General and Administrative Expense | $3.5B | $3.2B | $3.2B | $3.2B |
| Amortization of Intangibles | $644.0M | $685.0M | $683.0M | $702.0M |
| Restructuring and asset related charges - net | $146.0M | $288.0M | — | $363.0M |
| Business Separation Costs | $35.0M | — | — | — |
| Other income (expense) - net | ($570.0M) | ($300.0M) | ($448.0M) | ($60.0M) |
| Interest Expense | $180.0M | $233.0M | $233.0M | $79.0M |
| Income (loss) from continuing operations before income taxes | $1.7B | $1.3B | $1.1B | $1.4B |
| Provision for (benefit from) income taxes on continuing operations | $484.0M | $412.0M | $152.0M | $210.0M |
| Income (loss) from continuing operations after income taxes | $1.2B | $863.0M | $941.0M | $1.2B |
| Income (loss) from discontinued operations after income taxes | ($99.0M) | $56.0M | ($194.0M) | ($58.0M) |
| Net income (loss) | $1.1B | $919.0M | $747.0M | $1.2B |
| Net income (loss) attributable to noncontrolling interests | $11.0M | $12.0M | $12.0M | — |
| Net Income (Loss) attributable to Company | $1.1B | $907.0M | $735.0M | $1.1B |
| Basic earnings (loss) per share of common stock from continuing operations | $1.75 | $1.23 | $1.31 | $1.67 |
| Basic earnings (loss) per share of common stock from discontinued operations | -$0.15 | $0.08 | -$0.27 | -$0.08 |
| Basic earnings (loss) per share of common stock | $1.60 | $1.31 | $1.04 | $1.59 |
| Diluted earnings (loss) per share of common stock from continuing operations | $1.75 | $1.22 | $1.30 | $1.66 |
| Diluted earnings (loss) per share of common stock from discontinued operations | -$0.15 | $0.08 | -$0.27 | -$0.08 |
| Diluted earnings (loss) per share of common stock | $1.60 | $1.30 | $1.03 | $1.58 |
| Line item | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 | Jun 30, 2025 · Q2 |
|---|---|---|---|---|
| Net Sales | $6.4B | $4.9B | $2.6B | $6.5B |
| Cost of Goods Sold | $2.7B | $2.4B | $1.6B | $2.9B |
| Research and Development Expense | $388.0M | $341.0M | $351.0M | $375.0M |
| Selling, General and Administrative Expenses | $1.2B | $877.0M | $725.0M | $1.2B |
| Amortization of Intangibles | $194.0M | $160.0M | $162.0M | $161.0M |
| Restructuring and asset related charges - net | $49.0M | $92.0M | $30.0M | $79.0M |
| Business Separation Costs | $79.0M | $52.0M | $7.0M | — |
| Other income (expense) - net | ($115.0M) | ($117.0M) | ($23.0M) | $103.0M |
| Interest Expense | $47.0M | $36.0M | $46.0M | $52.0M |
| Income (loss) from continuing operations before income taxes | $1.6B | $858.0M | ($370.0M) | $1.8B |
| Provision for (benefit from) income taxes on continuing operations | $408.0M | $133.0M | ($62.0M) | $422.0M |
| Income (loss) from continuing operations after income taxes | $1.2B | $725.0M | ($308.0M) | $1.4B |
| (Income) loss from discontinued operations after income taxes | ($52.0M) | ($2.0M) | ($10.0M) | ($66.0M) |
| Net income (loss) | $1.2B | $723.0M | ($318.0M) | $1.3B |
| Net income (loss) attributable to noncontrolling interests | $4.0M | $3.0M | $2.0M | $2.0M |
| Net income (loss) attributable to Corteva | $1.2B | $720.0M | ($320.0M) | $1.3B |
| Basic earnings (loss) per share of common stock from continuing operations | $1.81 | $1.07 | -$0.46 | $2.02 |
| Basic earnings (loss) per share of common stock from discontinued operations | -$0.08 | $0.00 | -$0.01 | -$0.10 |
| Basic earnings (loss) per share of common stock | $1.73 | $1.07 | -$0.47 | $1.92 |
| Diluted earnings (loss) per share of common stock from continuing operations | $1.81 | $1.07 | -$0.46 | $2.02 |
| Diluted earnings (loss) per share of common stock from discontinued operations | -$0.08 | $0.00 | -$0.01 | -$0.10 |
| Diluted earnings (loss) per share of common stock | $1.73 | $1.07 | -$0.47 | $1.92 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and Cash Equivalents | $4.5B | $3.1B | $2.6B | $3.2B |
| Marketable Securities | $9.0M | $63.0M | $98.0M | $124.0M |
| Accounts and notes receivable - net | $6.4B | $5.7B | $5.5B | $5.7B |
| Inventories | $5.7B | $5.4B | $6.9B | $6.8B |
| Other current assets | $767.0M | $820.0M | $1.1B | $968.0M |
| Total current assets | $17.3B | $15.1B | $16.3B | $16.8B |
| Investments in nonconsolidated affiliates | $160.0M | $134.0M | $115.0M | $102.0M |
| Property, Plant and Equipment | $9.6B | $9.1B | $9.0B | $8.6B |
| Less: Accumulated Depreciation | $5.3B | $5.0B | $4.7B | $4.3B |
| Net Property, Plant and Equipment | $4.2B | $4.1B | $4.3B | $4.3B |
| Goodwill | $10.5B | $10.4B | $10.6B | $10.0B |
| Other intangible assets | $8.3B | $8.9B | $9.6B | $9.3B |
| Deferred Income Taxes | $320.0M | $401.0M | $584.0M | $479.0M |
| Other Assets | $2.0B | $1.8B | $1.5B | $1.7B |
| Total Assets | $42.8B | $40.8B | $43.0B | $42.6B |
| Short-term borrowings and finance lease obligations | $894.0M | $750.0M | $198.0M | $24.0M |
| Accounts Payable | $4.4B | $4.0B | $4.3B | $4.9B |
| Income Taxes Payable | $155.0M | $207.0M | $174.0M | $183.0M |
| Deferred Revenue | $3.6B | $3.3B | $3.4B | $3.4B |
| Accrued and other current liabilities | $3.1B | $2.1B | $2.4B | $2.3B |
| Total current liabilities | $12.1B | $10.4B | $10.4B | $10.7B |
| Long-term Debt | $1.7B | $2.0B | $2.3B | $1.3B |
| Deferred Income Tax Liabilities | $251.0M | $478.0M | $899.0M | $1.1B |
| Pension and other post employment benefits - noncurrent | $2.4B | $2.3B | $2.5B | $2.3B |
| Other noncurrent obligations | $2.0B | $1.7B | $1.7B | $1.7B |
| Total Noncurrent Liabilities | $6.3B | $6.4B | $7.3B | $6.3B |
| Common Stock, Shares, Issued | 672.2M | — | — | — |
| Common stock | $7.0M | $7.0M | $7.0M | $7.0M |
| Additional Paid in Capital | $27.0B | $27.2B | $27.7B | $27.9B |
| Retained earnings (accumulated deficit) | ($67.0M) | $55.0M | ($41.0M) | $250.0M |
| Accumulated other comprehensive income (loss) | ($2.8B) | ($3.5B) | ($2.7B) | ($2.8B) |
| Total stockholders' equity attributable to the company | $24.1B | $23.8B | $25.0B | $25.3B |
| Noncontrolling Interests | $242.0M | $241.0M | $242.0M | $239.0M |
| Total Equity | $24.4B | $24.0B | $25.3B | $25.5B |
| Total Liabilities and Equity | $42.8B | $40.8B | $43.0B | $42.6B |
| Line item | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 |
|---|---|---|---|---|
| Cash and cash equivalents | $2.4B | $2.0B | $2.5B | $2.1B |
| Marketable Securities | $0 | $2.0M | $77.0M | $76.0M |
| Accounts and notes receivable - net | $8.7B | $9.1B | $7.8B | $8.7B |
| Inventories | $4.4B | $5.2B | $5.3B | $4.3B |
| Other current assets | $853.0M | $1.1B | $758.0M | $873.0M |
| Total current assets | $16.4B | $17.4B | $16.4B | $16.0B |
| Investments in nonconsolidated affiliates | $145.0M | $165.0M | $141.0M | $134.0M |
| Property, Plant and Equipment | $9.7B | $9.6B | $9.6B | $9.5B |
| Less: Accumulated Depreciation | $5.6B | $5.4B | $5.4B | $5.3B |
| Net Property, Plant and Equipment | $4.2B | $4.2B | $4.2B | $4.2B |
| Goodwill | $10.4B | $10.4B | $10.5B | $10.5B |
| Other intangible assets | $8.0B | $8.1B | $8.4B | $8.6B |
| Deferred Income Taxes | $335.0M | $395.0M | $434.0M | $449.0M |
| Other assets | $2.2B | $2.0B | $2.0B | $1.9B |
| Total Assets | $41.6B | $42.7B | $42.2B | $41.8B |
| Short-term borrowings | $3.2B | $1.7B | $2.7B | $1.9B |
| Accounts payable | $4.0B | $4.2B | $4.3B | $3.8B |
| Income Taxes Payable | $303.0M | $229.0M | $254.0M | $485.0M |
| Deferred Revenue | $383.0M | $2.8B | $483.0M | $358.0M |
| Accrued and other current liabilities | $3.0B | $3.0B | $2.7B | $2.9B |
| Total current liabilities | $10.8B | $11.9B | $10.4B | $9.5B |
| Long-term Debt | $1.7B | $1.7B | $1.7B | $1.7B |
| Deferred income tax liabilities | $512.0M | $290.0M | $373.0M | $258.0M |
| Pension and other post employment benefits - noncurrent | $1.3B | $2.4B | $2.2B | $2.2B |
| Other noncurrent obligations | $2.0B | $1.9B | $2.0B | $1.9B |
| Total noncurrent liabilities | $5.5B | $6.3B | $6.3B | $6.1B |
| Common stock | $7.0M | $7.0M | $7.0M | $7.0M |
| Additional Paid in Capital | $26.9B | $26.9B | $27.0B | $27.0B |
| Retained earnings (accumulated deficit) | $1.2B | $436.0M | $834.0M | $1.5B |
| Accumulated Other Comprehensive Income (Loss) | ($3.0B) | ($2.9B) | ($2.7B) | ($2.6B) |
| Total stockholders' equity attributable to the company | $25.2B | $24.4B | $25.2B | $25.9B |
| Noncontrolling Interests | $244.0M | $243.0M | $242.0M | $242.0M |
| Total Equity | $25.4B | $24.6B | $25.5B | $26.2B |
| Liabilities and Equity | $41.6B | $42.7B | $42.2B | $41.8B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $1.1B | $919.0M | $747.0M | $1.2B |
| (Income) Loss from Discontinued Operations, after income taxes | $99.0M | ($56.0M) | $194.0M | — |
| Depreciation and amortization | $1.2B | $1.2B | $1.2B | $1.2B |
| Provision for (benefit from) deferred income tax | ($41.0M) | ($365.0M) | ($438.0M) | ($286.0M) |
| Net periodic pension and OPEB (benefit) cost, net | $36.0M | $160.0M | $138.0M | — |
| Pension and OPEB contributions | ($136.0M) | ($151.0M) | $149.0M | $182.0M |
| Net (gain) loss on sales of property, businesses, consolidated companies and investments | ($41.0M) | ($17.0M) | — | — |
| Restructuring and Asset Related Charges - net | $146.0M | $288.0M | $336.0M | $363.0M |
| Other net loss | $545.0M | $383.0M | $578.0M | $305.0M |
| Accounts and Notes Receivable | ($261.0M) | ($705.0M) | $358.0M | ($997.0M) |
| Inventories | ($35.0M) | $1.1B | $57.0M | ($1.7B) |
| Accounts Payable | $231.0M | ($115.0M) | ($663.0M) | $807.0M |
| Deferred Revenue | $270.0M | ($86.0M) | ($11.0M) | $194.0M |
| Other Assets and Liabilities | $336.0M | ($296.0M) | ($527.0M) | $162.0M |
| Cash Provided by (Used for) Operating Activities - Continuing Operations | $3.5B | $2.3B | $1.8B | — |
| Cash Provided by (Used for) Operating Activities - Discontinued Operations | ($51.0M) | ($151.0M) | ($40.0M) | — |
| Cash provided by (used for) operating activities | $3.4B | $2.1B | $1.8B | $872.0M |
| Capital expenditures | ($591.0M) | ($597.0M) | ($595.0M) | ($605.0M) |
| Net payment from (advances to) Parent on in-house banking arrangement | $0 | $361.0M | — | — |
| Proceeds from Sales of property, businesses, and consolidated companies - net of cash divested | $54.0M | $5.0M | — | — |
| Acquisitions of businesses - Net of Cash Acquired | $0 | $0 | ($1.5B) | — |
| Investments in and loans to nonconsolidated affiliates | ($20.0M) | ($7.0M) | ($32.0M) | ($12.0M) |
| Purchases of investments | $0 | ($144.0M) | ($148.0M) | ($344.0M) |
| Proceeds from Sale and Maturities of Investments | $135.0M | $130.0M | $147.0M | $295.0M |
| Payments for (Proceeds from) Hedge, Investing Activities | ($83.0M) | — | — | — |
| Other investing activities - net | ($38.0M) | ($39.0M) | ($2.0M) | ($3.0M) |
| Cash provided by (used for) investing activities | ($543.0M) | ($589.0M) | ($2.0B) | ($632.0M) |
| Net Change in borrowings (less than 90 days) | $0 | $53.0M | ($6.0M) | ($13.0M) |
| Net payment from (advances to) Parent on in-house banking arrangement | $129.0M | — | — | — |
| Repayments of Related Party Debt | $0 | $0 | ($818.0M) | ($1.4B) |
| Proceeds from Debt | $1.7B | $3.1B | $3.4B | $1.4B |
| Payments on Debt | ($1.9B) | ($2.9B) | ($2.3B) | ($1.1B) |
| Repurchase of Common Stock | ($1.1B) | ($1.0B) | ($756.0M) | ($1.0B) |
| Proceeds from Exercise of Stock Options | $88.0M | $60.0M | $31.0M | $88.0M |
| Dividends Paid to stockholders | ($475.0M) | ($458.0M) | ($439.0M) | ($418.0M) |
| Other financing activities, net | ($45.0M) | ($32.0M) | ($49.0M) | ($55.0M) |
| Cash provided by (used for) financing activities | ($1.6B) | ($1.2B) | ($99.0M) | ($1.2B) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | $84.0M | ($93.0M) | ($143.0M) | ($278.0M) |
| Increase (decrease) on cash, cash equivalents and restricted cash | $1.3B | $264.0M | ($460.0M) | ($1.2B) |
| Cash, cash equivalents and restricted cash equivalents at beginning of period | $3.4B | $3.2B | $3.6B | $4.8B |
| Cash, cash equivalents and restricted cash equivalents at end of period | $4.7B | $3.4B | $3.2B | $3.6B |
| Interest, net of amounts capitalized | $191.0M | $244.0M | $234.0M | $75.0M |
| Income Taxes | $750.0M | $707.0M | $535.0M | $467.0M |
| Line item | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD | Jun 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $1.9B | $723.0M | $1.7B | $2.0B |
| (Income) loss from discontinued operations after income taxes | $54.0M | $2.0M | $87.0M | $77.0M |
| Depreciation and Amortization | $636.0M | $297.0M | $897.0M | $597.0M |
| Provision for (benefit from) deferred income tax | $232.0M | ($52.0M) | ($72.0M) | ($209.0M) |
| Net Periodic Pension and OPEB (benefit) cost, net | ($5.0M) | ($3.0M) | $27.0M | $19.0M |
| Pension and OPEB Contributions | ($1.1B) | ($48.0M) | ($110.0M) | ($84.0M) |
| Net (gain) loss on sales of property, businesses, consolidated companies, and investments | $6.0M | $3.0M | ($17.0M) | ($17.0M) |
| Restructuring and asset related charges - net | $141.0M | $92.0M | $131.0M | $101.0M |
| Other net loss | $319.0M | $157.0M | $386.0M | $272.0M |
| Accounts and notes receivable | ($2.4B) | ($2.8B) | ($1.7B) | ($2.5B) |
| Inventories | $1.2B | $439.0M | $331.0M | $1.3B |
| Accounts Payable | ($487.0M) | ($221.0M) | $123.0M | ($356.0M) |
| Deferred Revenue | ($3.2B) | ($790.0M) | ($2.8B) | ($2.9B) |
| Other Assets and Liabilities | ($613.0M) | ($674.0M) | $105.0M | $667.0M |
| Cash Provided by (Used for) Operating Activities, Continuing Operations | ($3.3B) | ($2.9B) | ($941.0M) | ($1.1B) |
| Cash Provided by (Used for) Operating Activities, Discontinued Operations | ($12.0M) | ($6.0M) | ($28.0M) | ($23.0M) |
| Cash Provided by (Used for) Operating Activities | ($3.4B) | ($2.9B) | ($969.0M) | ($1.2B) |
| Capital expenditures | ($203.0M) | ($81.0M) | ($369.0M) | ($212.0M) |
| Proceeds from sales of property, businesses, and consolidated companies - net of cash divested | $1.0M | $0 | $26.0M | $25.0M |
| Payments to Acquire Businesses, Net of Cash Acquired | ($43.0M) | — | — | — |
| Investments in and loans to nonconsolidated affiliates | ($6.0M) | ($3.0M) | ($7.0M) | — |
| Proceeds from Sale and Maturities of Investments | $9.0M | $8.0M | $68.0M | $62.0M |
| Proceeds from (payments for) settlement of net investment hedge | $0 | — | ($56.0M) | ($56.0M) |
| Other investing activities - net | ($5.0M) | ($1.0M) | ($17.0M) | ($17.0M) |
| Cash provided by (used for) investing activities | ($247.0M) | ($77.0M) | ($355.0M) | ($198.0M) |
| Net change in borrowings (less than 90 days) | $2.4B | $521.0M | $1.1B | $28.0M |
| Net payments from (advances to) Parent on in-house banking arrangement | ($9.0M) | $0 | $0 | $0 |
| Proceeds from debt | $868.0M | $268.0M | $1.6B | $1.2B |
| Payments on Debt | ($989.0M) | ($22.0M) | ($1.1B) | ($335.0M) |
| Repurchase of Common Stock | ($500.0M) | ($250.0M) | ($770.0M) | ($520.0M) |
| Proceeds from Exercise of Stock Options | $31.0M | $17.0M | $75.0M | $70.0M |
| Dividends paid to stockholders | ($241.0M) | ($121.0M) | ($354.0M) | ($232.0M) |
| Other financing activities, net | ($37.0M) | ($24.0M) | ($43.0M) | ($38.0M) |
| Cash provided by (used for) financing activities | $1.5B | $389.0M | $554.0M | $187.0M |
| Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash Equivalents | ($32.0M) | ($5.0M) | $85.0M | $68.0M |
| Increase (Decrease) in Cash, Cash Equivalents, Restricted Cash | ($2.1B) | ($2.6B) | ($685.0M) | ($1.1B) |
| Cash, Cash Equivalents and Restricted Cash Equivalents at Beginning of Period | $4.7B | $4.7B | $3.4B | $3.4B |
| Cash, Cash Equivalents and Restricted Cash Equivalents at End of Period | $2.6B | $2.1B | — | — |
Corteva Inc score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.